Shanghai eye treatment outbreak: bevacizumab therapy for AMD in China-Reference-Cited by-同舟云学术

Shanghai eye treatment outbreak: bevacizumab therapy for AMD in China

Published:2013-01-01 Issue:1 Volume:96 Page:106-108
ISSN:0816-4622
Container-title:Clinical and Experimental Optometry
language:en
Short-container-title:Clinical and Experimental Optometry

Author:

Huang Hong‐bing¹,Pan Ying¹,Liu Tao¹

Affiliation:

1. State Key Laboratory of Oncology in South China, Department of Pharmacy, Tumor Hospital affiliated to Sun Yat‐Sen University, Guangdong, Guangzhou, China,

Publisher

Informa UK Limited

Subject

Optometry,Ophthalmology

Link

https://www.tandfonline.com/doi/pdf/10.1111/j.1444-0938.2012.00812.x

Reference24 articles.

1. The Epidemiology of Age-Related Macular Degeneration

2. Potential Public Health Impact of Age-Related Eye Disease Study Results

3. The epidemiology of age-related macular degeneration

4. Causes and Prevalence of Visual Impairment Among Adults in the UnitedStates

5. Racial Variations in Causes of Vision Loss in Nursing Homes

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of three successive treatments of ranibizumab on neovascular macular degeneration by OCT angiography;Experimental and Therapeutic Medicine;2020-11-19

2. Analytical Similarity of a Proposed Biosimilar BVZ-BC to Bevacizumab;Analytical Chemistry;2020-01-25

3. A Multinational Comparison of Anti–Vascular Endothelial Growth Factor Use: The United States, the United Kingdom, and Asia-Pacific;Ophthalmology Retina;2019-01

4. Different Strategies for the Treatment of Age-Related Macular Degeneration in China: An Economic Evaluation;Journal of Ophthalmology;2016